New therapies after failure of angiogenesis inhibitors.
Escudier
Bernard
B
Immunotherapy and Innovative Therapy Unit, Gustave-Roussy Institute, Paris, France.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors